{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T02:25:16Z","timestamp":1784859916230,"version":"3.55.0"},"reference-count":121,"publisher":"Springer Science and Business Media LLC","issue":"2","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s13555-016-0117-6","type":"journal-article","created":{"date-parts":[[2016,4,16]],"date-time":"2016-04-16T07:00:39Z","timestamp":1460790039000},"page":"125-142","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["Systemic Treatment of Pediatric Psoriasis: A Review"],"prefix":"10.1007","volume":"6","author":[{"given":"Maddalena","family":"Napolitano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Megna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Balato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Ayala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Lembo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Villani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Balato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,16]]},"reference":[{"key":"117_CR1","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1001\/archderm.143.12.1559","volume":"143","author":"C Huerta","year":"2007","unstructured":"Huerta C, Rivero E, Rodriguez LA. Incidence and risk factors for psoriasis in the general population. Arch Dermatol. 2007;143:1559\u201365.","journal-title":"Arch Dermatol"},{"key":"117_CR2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2174\/1573400511666150504125456","volume":"11","author":"Matteo Megna","year":"2015","unstructured":"Megna Matteo, Napolitano Maddalena, Balato A, et al. Psoriasis in children: a review. Curr Pediatr Rev. 2015;11:10\u201326.","journal-title":"Curr Pediatr Rev."},{"key":"117_CR3","first-page":"815","volume":"9","author":"M Sticherling","year":"2011","unstructured":"Sticherling M, Augustin M, Boehncke WH, et al. Therapy of psoriasis in childhood and adolescence\u2014 a German expert consensus. J Dtsch Dermatol Ges. 2011;9:815\u201323.","journal-title":"J Dtsch Dermatol Ges."},{"key":"117_CR4","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jaad.2009.07.029","volume":"62","author":"MM Tollefson","year":"2010","unstructured":"Tollefson MM, Crowson CS, McEvoy MT, Maradit Kremers H. Incidence of psoriasis in children: a population-based study. J Am Acad Dermatol. 2010;62:979\u201387.","journal-title":"J Am Acad Dermatol"},{"key":"117_CR5","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jaad.2008.10.062","volume":"60","author":"M Icen","year":"2009","unstructured":"Icen M, Crowson CS, McEvoy MT, Dann FJ, Gabriel SE, Maradit Kremers H. Trends in incidence of adult-onset psoriasis over three decades: a population-based study. J Am Acad Dermatol. 2009;60:394\u2013401.","journal-title":"J Am Acad Dermatol"},{"key":"117_CR6","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1046\/j.1525-1470.2000.01746.x","volume":"17","author":"SP Raychaudhuri","year":"2000","unstructured":"Raychaudhuri SP, Gross J. A comparative study of pediatric onset psoriasis with adult onset psoriasis. Pediatr Dermatol. 2000;17:174\u20138.","journal-title":"Pediatr Dermatol"},{"key":"117_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000251595","volume":"148","author":"EM Farber","year":"1974","unstructured":"Farber EM, Nall ML. The natural history of psoriasis in 5,600 patients. Dermatologica. 1974;148:1\u201318.","journal-title":"Dermatologica"},{"key":"117_CR8","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.clindermatol.2007.08.006","volume":"25","author":"E Christophers","year":"2007","unstructured":"Christophers E. Comorbidities in psoriasis. Clin Dermatol. 2007;25:529\u201334.","journal-title":"Clin Dermatol"},{"key":"117_CR9","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1365-2133.2009.09505.x","volume":"161","author":"CH Smith","year":"2009","unstructured":"Smith CH, Anstay VA, Barker JN, et al. British Association of Dermatologists\u2019 guidelines for biologic interventions for psoriasis 2009. Br J Dermatol. 2009;161:987\u20131019.","journal-title":"Br J Dermatol"},{"key":"117_CR10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jaad.2010.11.055","volume":"65","author":"A Menter","year":"2011","unstructured":"Menter A, Korman NJ, Elmets CA, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section\u00a06. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions. J Am Acad Dermatol. 2011;65:137\u201374.","journal-title":"J Am Acad Dermatol"},{"key":"117_CR11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2147\/AHMT.S36672","volume":"5","author":"C Fotiadou","year":"2014","unstructured":"Fotiadou C, Lazaridou E, Ioannides D. Management of psoriasis in adolescence. Adolesc Health Med Ther. 2014;5:25\u201334.","journal-title":"Adolesc Health Med Ther."},{"key":"117_CR12","first-page":"1","volume":"13","author":"KM Cordoro","year":"2008","unstructured":"Cordoro KM. Systemic and light therapies for the management of childhood psoriasis: part II. Skin Therapy Lett. 2008;13:1\u20133.","journal-title":"Skin Therapy Lett."},{"key":"117_CR13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1600-0781.2004.00084.x","volume":"20","author":"SA Holme","year":"2004","unstructured":"Holme SA, Anstey AV. Phototherapy and PUVA photochemotherapy in children. Photodermatol Photoimmunol Photomed. 2004;20:69\u201375.","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"117_CR14","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1001\/archderm.1997.03890480034005","volume":"133","author":"TR Coven","year":"1997","unstructured":"Coven TR, Burack LH, Gilleaudeau R, Keogh M, Ozawa M, Krueger JG. Narrowband UV-B produces superior clinical and histopathological resolution of moderate-to-severe psoriasis in patients compared with broadband UV-B. Arch Dermatol. 1997;133:1514\u201322.","journal-title":"Arch Dermatol"},{"key":"117_CR15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4137\/CMPed.S8045","volume":"7","author":"I Lara-Corrales","year":"2013","unstructured":"Lara-Corrales I, Ramnarine S, Lansang P. Treatment of childhood psoriasis with phototherapy and photochemotherapy. Clin Med Insights Pediatr. 2013;7:25\u201333.","journal-title":"Clin Med Insights Pediatr."},{"key":"117_CR16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1525-1470.2003.03016.x","volume":"20","author":"A Pasic","year":"2003","unstructured":"Pasic A, Ceovic R, Lipozencic J, et al. Phototherapy in pediatric patients. Pediatr Dermatol. 2003;20:71\u20137.","journal-title":"Pediatr Dermatol"},{"key":"117_CR17","doi-asserted-by":"crossref","first-page":"357","DOI":"10.4103\/0378-6323.66580","volume":"76","author":"S Dogra","year":"2010","unstructured":"Dogra S, Kaur I. Childhood psoriasis. Indian J Dermatol Venereol Leprol. 2010;76:357\u201365.","journal-title":"Indian J Dermatol Venereol Leprol."},{"key":"117_CR18","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/j.1365-2133.2004.06181.x","volume":"151","author":"T Kopp","year":"2004","unstructured":"Kopp T, Karlhofer F, Sz\u00e9pfalusi Z, Schneeberger A, Stingl G, Tanew A. Successful use of acitretin in conjunction with narrowband ultraviolet B phototherapy in a child with severe pustular psoriasis, von Zumbusch type. Br J Dermatol. 2004;151:912\u20136.","journal-title":"Br J Dermatol"},{"key":"117_CR19","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.det.2012.12.005","volume":"31","author":"A Marqueling","year":"2013","unstructured":"Marqueling A, Cordoro KM. Systemic treatments for severe pediatric psoriasis: a practical approach. Dermatol Clin. 2013;31:267\u201388.","journal-title":"Dermatol Clin"},{"key":"117_CR20","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1468-3083.2010.03832.x","volume":"25","author":"M Pavlovsky","year":"2011","unstructured":"Pavlovsky M, Baum S, Shpiro D, Pavlovsky L, Pavlotsky F. Narrow band UVB: is it effective and safe for paediatric psoriasis and atopic dermatitis? J Eur Acad Dermatol Venereol. 2011;25:727\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"117_CR21","doi-asserted-by":"crossref","first-page":"e221","DOI":"10.1111\/pde.12632","volume":"32","author":"Y Wong","year":"2015","unstructured":"Wong Y, Koh MJ, Chong WS. Role of narrowband ultraviolet B phototherapy in the treatment of childhood psoriasis in Asian children. Pediatr Dermatol. 2015;32:e221\u20133.","journal-title":"Pediatr Dermatol"},{"key":"117_CR22","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1525-1470.1995.tb00132.x","volume":"12","author":"AS al-Fouzan","year":"1995","unstructured":"al-Fouzan AS, Nanda A. UVB phototherapy in childhood psoriasis. Pediatr Dermatol. 1995;12:66.","journal-title":"Pediatr Dermatol."},{"key":"117_CR23","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1525-1470.1996.tb00711.x","volume":"13","author":"YK Tay","year":"1996","unstructured":"Tay YK, Morelli JG, Weston WL. Experience with UVB phototherapy in children. Pediatr Dermatol. 1996;13:406\u20139.","journal-title":"Pediatr Dermatol"},{"key":"117_CR24","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1365-4632.2007.03148.x","volume":"46","author":"VK Jain","year":"2007","unstructured":"Jain VK, Aggarwal K, Jain K, Bansal A. Narrow-band UV-B phototherapy in childhood psoriasis. Int J Dermatol. 2007;46:320\u20132.","journal-title":"Int J Dermatol"},{"key":"117_CR25","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1468-3083.2009.03425.x","volume":"24","author":"P Zamberk","year":"2010","unstructured":"Zamberk P, Velazquez D, Campos M, Hernanz JM, L\u00e1zaro P. Paediatric psoriasis: narrowband UVB treatment. J Eur Acad Dermatol Venereol. 2010;24:415\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"117_CR26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1365-2133.1990.tb02889.x","volume":"122","author":"K Wolff","year":"1990","unstructured":"Wolff K. Side-effects of psoralen photochemotherapy (PUVA). Br J Dermatol. 1990;122:117\u201325.","journal-title":"Br J Dermatol"},{"key":"117_CR27","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s40257-013-0026-8","volume":"14","author":"KN Shah","year":"2013","unstructured":"Shah KN. Diagnosis and treatment of pediatric psoriasis: current and future. Am J Clin Dermatol. 2013;14:195\u2013213.","journal-title":"Am J Clin Dermatol"},{"key":"117_CR28","doi-asserted-by":"publisher","unstructured":"Charbit L, Mah\u00e9 E, Phan A, et al. Systemic treatments in childhood psoriasis: a French multicentre study on 154 children. Br J Dermatol. 2015. doi: 10.1111\/bjd.14326 . [Epub ahead of print].","DOI":"10.1111\/bjd.14326"},{"key":"117_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5070\/D3203021769","volume":"20","author":"J Zweegers","year":"2014","unstructured":"Zweegers J, de Jong EM, Nijsten TE, et al. Summary of the Dutch S3-guidelines on the treatment of psoriasis 2011. Dermatol Online J. 2014;20:1\u2013112.","journal-title":"Dermatol Online J"},{"key":"117_CR30","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1517\/14656566.6.10.1725","volume":"6","author":"CS Lee","year":"2005","unstructured":"Lee CS, Koo J. A review of acitretin, a systemic retinoid for the treatment of psoriasis. Expert Opin Pharmacother. 2005;6:1725\u201334.","journal-title":"Expert Opin Pharmacother"},{"key":"117_CR31","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.jaad.2009.06.048","volume":"62","author":"ME Jager de","year":"2010","unstructured":"de Jager ME, de Jong EM, van de Kerkhof PC, Seyger MM. Efficacy and safety of treatments for childhood psoriasis: a systematic literature review. J Am Acad Dermatol. 2010;62:1013\u201330.","journal-title":"J Am Acad Dermatol"},{"key":"117_CR32","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/j.1365-2133.1996.tb07936.x","volume":"134","author":"M Lacour","year":"1996","unstructured":"Lacour M, Mehta-Nikhar B, Atherton DJ, Harper JI. An appraisal of acitretin therapy in children with inherited disorders of keratinization. Br J Dermatol. 1996;134:1023\u20139.","journal-title":"Br J Dermatol"},{"key":"117_CR33","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1067\/S0190-9622(03)01564-0","volume":"49","author":"AR Brecher","year":"2003","unstructured":"Brecher AR, Orlow SJ. Oral retinoid therapy for dermatologic conditions in children and adolescents. J Am Acad Dermatol. 2003;49:171\u201382.","journal-title":"J Am Acad Dermatol"},{"key":"117_CR34","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2133.2005.06906.x","volume":"154","author":"RP Katugampola","year":"2006","unstructured":"Katugampola RP, Finlay AY. Oral retinoid therapy for disorders of keratinization: single-centre retrospective 25\u00a0years\u2019 experience on 23 patients. Br J Dermatol. 2006;154:267\u201376.","journal-title":"Br J Dermatol"},{"key":"117_CR35","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2310\/7750.2006.00065","volume":"10","author":"CP Halverstam","year":"2006","unstructured":"Halverstam CP, Zeichner J, Lebwohl M. Lack of significant skeletal changes after long-term, low-dose retinoid therapy: case report and review of the literature. J Cutan Med Surg. 2006;10:291\u20139.","journal-title":"J Cutan Med Surg."},{"key":"117_CR36","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1365-2133.1996.d01-742.x","volume":"134","author":"RJ Dooren-Greebe Van","year":"1996","unstructured":"Van Dooren-Greebe RJ, Lemmens JA, De Boo T, Hangx NM, Kuijpers AL, Van de Kerkhof PC. Prolonged treatment with oral retinoids in adults: no influence on the frequency and severity of spinal abnormalities. Br J Dermatol. 1996;134:71\u20136.","journal-title":"Br J Dermatol"},{"key":"117_CR37","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.1365-2230.2003.01265.x","volume":"28","author":"EA McMullen","year":"2003","unstructured":"McMullen EA, McCarron P, Irvine AD, Dolan OM, Allen GE. Association between long-term acitretin therapy and osteoporosis: no evidence of increased risk. Clin Exp Dermatol. 2003;28:307\u20139.","journal-title":"Clin Exp Dermatol"},{"key":"117_CR38","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1525-1470.2010.01084.x","volume":"27","author":"ST Oliveira de","year":"2010","unstructured":"de Oliveira ST, Maragno L, Arnone M, Fonseca Takahashi MD, Romiti R. Generalized pustular psoriasis in childhood. Pediatr Dermatol. 2010;27:349\u201354.","journal-title":"Pediatr Dermatol"},{"key":"117_CR39","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1346-8138.2007.00334.x","volume":"34","author":"T Xiao","year":"2007","unstructured":"Xiao T, Li B, He CD, Chen HD. Juvenile generalized pustular psoriasis. J Dermatol. 2007;34:573\u20136.","journal-title":"J Dermatol"},{"key":"117_CR40","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1046\/j.1525-1470.1998.1998015144.x","volume":"15","author":"G Juanqin","year":"1998","unstructured":"Juanqin G, Zhiqiang C, Zijia H. Evaluation of the effectiveness of childhood generalized pustular psoriasis treatment in 30 cases. Pediatr Dermatol. 1998;15:144\u20136.","journal-title":"Pediatr Dermatol"},{"key":"117_CR41","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1525-1470.2009.00918.x","volume":"26","author":"PH Chao","year":"2009","unstructured":"Chao PH, Cheng YW, Chung MY. Generalized pustular psoriasis in a 6-week-old infant. Pediatr Dermatol. 2009;26:352\u20134.","journal-title":"Pediatr Dermatol"},{"key":"117_CR42","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1525-1470.1995.tb00165.x","volume":"12","author":"M Salleras","year":"1995","unstructured":"Salleras M, Sanchez-Regana M, Umbert P. Congenital erythrodermic psoriasis: case report and literature review. Pediatr Dermatol. 1995;12:231\u20134.","journal-title":"Pediatr Dermatol"},{"key":"117_CR43","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1365-2230.1993.tb00985.x","volume":"18","author":"MR Judge","year":"1993","unstructured":"Judge MR, McDonald A, Black MM. Pustular psoriasis in childhood. Clin Exp Dermatol. 1993;18:97\u20139.","journal-title":"Clin Exp Dermatol"},{"key":"117_CR44","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1080\/09546630802132643","volume":"19","author":"S Ergin","year":"2008","unstructured":"Ergin S, Ersoy-Evans S, Sahin S, Ozkaya O. Acitretin is a safe treatment option for infantile pustular psoriasis. J Dermatol Treat. 2008;19:341\u20133.","journal-title":"J Dermatol Treat."},{"key":"117_CR45","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1080\/000155598441576","volume":"78","author":"T Karamfilov","year":"1998","unstructured":"Karamfilov T, Wollina U. Juvenile generalized pustular psoriasis. Acta Derm Venereol. 1998;78:220.","journal-title":"Acta Derm Venereol"},{"key":"117_CR46","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1046\/j.1525-1470.2002.00026.x","volume":"19","author":"PB Liao","year":"2002","unstructured":"Liao PB, Rubinson R, Howard R, Sanchez G, Frieden IJ. Annular pustular psoriasis: most common form of pustular psoriasis in children: report of three cases and review of the literature. Pediatr Dermatol. 2002;19:19\u201325.","journal-title":"Pediatr Dermatol"},{"key":"117_CR47","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1365-2230.2008.02976.x","volume":"33","author":"RB Warren","year":"2008","unstructured":"Warren RB, Chalmers RJ, Griffiths CE, Menter A. Methotrexate for psoriasis in the era of biological therapy. Clin Exp Dermatol. 2008;33:551\u20134.","journal-title":"Clin Exp Dermatol"},{"key":"117_CR48","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1525-1470.1985.tb01059.x","volume":"2","author":"AS Paller","year":"1985","unstructured":"Paller AS. Dermatologic uses of methotrexate in children: indications and guidelines. Pediatr Dermatol. 1985;2:238\u201343.","journal-title":"Pediatr Dermatol"},{"key":"117_CR49","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1365-2125.2002.01621.x","volume":"54","author":"J Chl\u00e1dek","year":"2002","unstructured":"Chl\u00e1dek J, Grim J, Mart\u00ednkov\u00e1 J, et al. Pharmacokinetics and pharmacodynamics of low-dose methotrexate in the treatment of psoriasis. Br J Clin Pharmacol. 2002;54:147\u201356.","journal-title":"Br J Clin Pharmacol"},{"key":"117_CR50","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.sder.2010.01.003","volume":"29","author":"NA Wright","year":"2010","unstructured":"Wright NA, Piggott CD, Eichenfield LF. The role of biologics and other systemic agents in the treatment of pediatric psoriasis. Semin Cutan Med Surg. 2010;29:20\u20137.","journal-title":"Semin Cutan Med Surg"},{"key":"117_CR51","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.jaad.2008.11.906","volume":"60","author":"RE Kalb","year":"2009","unstructured":"Kalb RE, Strober B, Weinstein G, Lebwohl M. Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference. J Am Acad Dermatol. 2009;60:824\u201337.","journal-title":"J Am Acad Dermatol"},{"key":"117_CR52","first-page":"812","volume":"8","author":"M St\u00e5hle","year":"2010","unstructured":"St\u00e5hle M, Atakan N, Boehncke WH, et al. Juvenile psoriasis and its clinical management: a European expert group consensus. J Dtsch Dermatol Ges. 2010;8:812\u20138.","journal-title":"J Dtsch Dermatol Ges."},{"key":"117_CR53","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1080\/09546630701247930","volume":"18","author":"P Gisondi","year":"2007","unstructured":"Gisondi P, Fantuzzi F, Malerba M, Girolomoni G. Folic acid in general medicine and dermatology. J Dermatolog Treat. 2007;18:138\u201346.","journal-title":"J Dermatolog Treat."},{"key":"117_CR54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-3083.2009.03389.x","volume":"23","author":"D Pathirana","year":"2009","unstructured":"Pathirana D, Ormerod AD, Saiag P, Smith C, Spuls PI, Nast A, et al. European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol. 2009;23:1\u201370.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"117_CR55","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1525-1470.2008.00629.x","volume":"25","author":"I Kaur","year":"2008","unstructured":"Kaur I, Dogra S, De D, Kanwar AJ. Systemic methotrexate treatment in childhood psoriasis: further experience in 24 children from India. Pediatr Dermatol. 2008;25:184\u20138.","journal-title":"Pediatr Dermatol"},{"key":"117_CR56","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/jdv.12749","volume":"29","author":"MJ Geel van","year":"2015","unstructured":"van Geel MJ, Mul K, de Jager ME, van de Kerkhof PC, de Jong EM, Seyger MM. Systemic treatments in paediatric psoriasis: a systematic evidence based update. J Eur Acad Dermatol Venereol. 2015;29:425\u201337.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"117_CR57","first-page":"1","volume":"20","author":"MJ Geel Van","year":"2015","unstructured":"Van Geel MJ, Oostveen AM, Hoppenreijs EP, et al. Methotrexate in pediatric plaque-type psoriasis: long-term daily clinical practice results from the Child-CAPTURE registry. J Dermatol Treat. 2015;20:1\u20137.","journal-title":"J Dermatol Treat."},{"key":"117_CR58","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/pde.12351","volume":"31","author":"CJ Posso-De Los Rios","year":"2014","unstructured":"Posso-De Los Rios CJ, Pope E, Lara-Corrales I. A systematic review of systemic medications for pustular psoriasis in pediatrics. Pediatr Dermatol. 2014;31:430\u20139.","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"117_CR59","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1046\/j.1525-1470.1998.1998015144.x","volume":"15","author":"G Juanqin","year":"1998","unstructured":"Juanqin G, Zhiqiang C, Zijia H. Evaluation of the effectiveness of childhood generalized pustular psoriasis treatment in 30 cases. Pediatr Dermatol. 1998;15(2):144\u20136.","journal-title":"Pediatr Dermatol"},{"key":"117_CR60","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1525-1470.1994.tb00602.x","volume":"11","author":"B Kumar","year":"1994","unstructured":"Kumar B, Dhar S, Handa S, Kaur I. Methotrexate in childhood psoriasis. Pediatr Dermatol. 1994;11:271\u20133.","journal-title":"Pediatr Dermatol"},{"key":"117_CR61","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.0736-8046.2004.21328.x","volume":"21","author":"S Dogra","year":"2004","unstructured":"Dogra S, Handa S, Kanwar AJ. Methotrexate in severe childhood psoriasis. Pediatr Dermatol. 2004;21:283\u20134.","journal-title":"Pediatr Dermatol"},{"key":"117_CR62","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1525-1470.2005.22122.x","volume":"22","author":"S Dogra","year":"2005","unstructured":"Dogra S, Kumaran MS, Handa S, Kanwar AJ. Methotrexate for generalized pustular psoriasis in a 2-year-old child. Pediatr Dermatol. 2005;22:85\u20136.","journal-title":"Pediatr Dermatol"},{"key":"117_CR63","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1525-1470.1996.tb01187.x","volume":"13","author":"G Kalla","year":"1996","unstructured":"Kalla G, Goyal AM. Juvenile generalized pustular psoriasis. Pediatr Dermatol. 1996;13:45\u20136.","journal-title":"Pediatr Dermatol"},{"key":"117_CR64","first-page":"190","volume":"9","author":"T Garg","year":"2011","unstructured":"Garg T, Chander R, Mittal S. Familial juvenile generalized pustular psoriasis: response to methotrexate. Skinmed. 2011;9:190\u20131.","journal-title":"Skinmed."},{"key":"117_CR65","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2230.2008.02907.x","volume":"34","author":"B Collin","year":"2009","unstructured":"Collin B, Vani A, Ogboli M, Moss C. Methotrexate treatment in 13 children with severe plaque psoriasis. Clin Exp Dermatol. 2009;34:295\u20138.","journal-title":"Clin Exp Dermatol"},{"key":"117_CR66","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1001\/archpedi.1968.02100020220018","volume":"116","author":"RB Scott","year":"1968","unstructured":"Scott RB, Surana R. Erythrodermic psoriasis in childhood: a young Negro child treated with methotrexate. Am J Dis Child. 1968;116:218\u201321.","journal-title":"Am J Dis Child"},{"key":"117_CR67","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1046\/j.1365-2133.1998.02490.x","volume":"139","author":"N Alli","year":"1998","unstructured":"Alli N, G\u03ccng\u03c6r E, Karakayali G, Lenk N, Art\u03ccz F. The use of cyclosporin in a child with generalized pustular psoriasis. Br J Dermatol. 1998;139:754\u20135.","journal-title":"Br J Dermatol"},{"key":"117_CR68","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/09546630310012136","volume":"14","author":"CM Perrett","year":"2003","unstructured":"Perrett CM, Ilchyshyn A, Berth-Jones J. Cyclosporin in childhood psoriasis. J Dermatolog Treat. 2003;14:113\u20138.","journal-title":"J Dermatolog Treat."},{"key":"117_CR69","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1468-3083.2006.01562.x","volume":"20","author":"TM Pereira","year":"2006","unstructured":"Pereira TM, Vieira AP, Fernandes JC, Sousa-Basto AJ. Cyclosporin A treatment in severe childhood psoriasis. J Eur Acad Dermatol Venereol. 2006;20:651\u20136.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"117_CR70","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1046\/j.1525-1470.2001.018003246.x","volume":"18","author":"SS Kili\u00e7","year":"2001","unstructured":"Kili\u00e7 SS, Hacimustafaog\u02c7lu M, Celebi S, Karadeniz A, Ildirim I. Low dose cyclosporin A treatment in generalized pustular psoriasis. Pediatr Dermatol. 2001;18:246\u20138.","journal-title":"Pediatr Dermatol"},{"key":"117_CR71","first-page":"1532","volume":"137","author":"E Mah\u00e9","year":"2001","unstructured":"Mah\u00e9 E, Bodemer C, Pruszkowski A, Teillac-Hamel D, de Prost Y. Cyclosporine in childhood psoriasis. Arch Dermatol. 2001;137:1532.","journal-title":"Arch Dermatol."},{"key":"117_CR72","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/S0190-9622(99)70363-4","volume":"41","author":"J Koo","year":"1999","unstructured":"Koo J. Systemic sequential therapy of psoriasis: a new paradigm for improved therapeutic results. J Am Acad Dermatol. 1999;41:S25\u20138.","journal-title":"J Am Acad Dermatol"},{"key":"117_CR73","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1067\/mjd.2001.117047","volume":"45","author":"M Lebwohl","year":"2001","unstructured":"Lebwohl M, Ali S. Treatment of psoriasis. Part 2. Systemic therapies. J Am Acad Dermatol. 2001;45:649\u201361.","journal-title":"J Am Acad Dermatol"},{"key":"117_CR74","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1365-4362.36.s1.3.x","volume":"36","author":"CN Ellis","year":"1997","unstructured":"Ellis CN. Safety issues with cyclosporine. Int J Dermatol. 1997;36:7\u201310.","journal-title":"Int J Dermatol"},{"key":"117_CR75","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1525-1470.2006.00247.x","volume":"23","author":"HS Kim","year":"2006","unstructured":"Kim HS, Kim GM, Kim SY. Two-stage therapy for childhood generalized pustular psoriasis: low-dose cyclosporin for induction and maintenance with acitretin\/narrowband ultraviolet B phototherapy. Pediatr Dermatol. 2006;23:306\u20138.","journal-title":"Pediatr Dermatol"},{"key":"117_CR76","doi-asserted-by":"crossref","first-page":"e1023","DOI":"10.1111\/j.1365-2230.2009.03702.x","volume":"34","author":"S Nakamura","year":"2009","unstructured":"Nakamura S, Hashimoto Y, Igawa S, et al. Childhood generalized pustular psoriasis treated by preprandial ciclosporin administration: serum cytokine pattern during the course of the disease. Clin Exp Dermatol. 2009;34:e1023\u20134.","journal-title":"Clin Exp Dermatol"},{"key":"117_CR77","doi-asserted-by":"crossref","unstructured":"Bulbul Baskan E, Yazici S, Tunali S, Saricaoglu H. Clinical experience with systemic cyclosporine A treatment in severe childhood psoriasis. J Dermatolog Treat. 2015:1\u20134 [Epub ahead of print].","DOI":"10.3109\/09546634.2015.1115813"},{"key":"117_CR78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/09546634.2015.1120852","volume":"10","author":"V Lernia Di","year":"2015","unstructured":"Di Lernia V, Stingeni L, Boccaletti V, et al. Effectiveness and safety of cyclosporine in pediatric plaque psoriasis: a multicentric retrospective analysis. J Dermatolog Treat. 2015;10:1\u20134.","journal-title":"J Dermatolog Treat."},{"key":"117_CR79","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2165\/00003495-198326010-00002","volume":"26","author":"A Ward","year":"1983","unstructured":"Ward A, Brogden RN, Heel RC, Speight TM, Avery GS. Etretinate. A review of its pharmacological properties and therapeutic efficacy in psoriasis and other skin disorders. Drugs. 1983;26:9\u201343.","journal-title":"Drugs."},{"key":"117_CR80","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/1346-8138.12481","volume":"41","author":"C Namba","year":"2014","unstructured":"Namba C, Murakami M, Hanakawa Y, et al. Infantile generalized pustular psoriasis: successful disease control with intermittent etretinate. J Dermatol. 2014;41:403\u20136.","journal-title":"J Dermatol."},{"key":"117_CR81","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1001\/archderm.1987.01660260100023","volume":"123","author":"LS Shelnitz","year":"1987","unstructured":"Shelnitz LS, Esterly NB, Honig PJ. Etretinate therapy for generalized pustular psoriasis in children. Arch Dermatol. 1987;123:230\u20133.","journal-title":"Arch Dermatol"},{"key":"117_CR82","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1046\/j.1365-4362.1997.00170.x","volume":"36","author":"YK Tay","year":"1997","unstructured":"Tay YK, Tham SN. The profile and outcome of pustular psoriasis in Singapore: a report of 28 cases. Int J Dermatol. 1997;36:266\u20137.","journal-title":"Int J Dermatol"},{"key":"117_CR83","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1525-1470.2011.01687.x","volume":"29","author":"Y Umezawa","year":"2012","unstructured":"Umezawa Y, Mabuch T, Ozawa A. Generalized pustular psoriasis in a child: observation of long-term combination therapy with etretinate and calcipotriol for 16 years. Pediatr Dermatol. 2012;29:206\u20138.","journal-title":"Pediatr Dermatol"},{"key":"117_CR84","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1525-1470.1988.tb00902.x","volume":"5","author":"D Rosi\u0144ska","year":"1988","unstructured":"Rosi\u0144ska D, Wolska H, Jablonska S, Konca I. Etretinate in severe psoriasis of children. Pediatr Dermatol. 1988;5:266\u201372.","journal-title":"Pediatr Dermatol"},{"key":"117_CR85","first-page":"837","volume":"34","author":"MJ Rood","year":"2007","unstructured":"Rood MJ, Lavrijsen SP, Huizinga TW. Acitretin-related ossification. J Rheumatol. 2007;34:837\u20138.","journal-title":"J Rheumatol"},{"key":"117_CR86","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.molmed.2004.11.003","volume":"11","author":"U Mrowietz","year":"2005","unstructured":"Mrowietz U, Asadullah K. Dimethylfumarate for psoriasis: more than a dietary curiosity. Trends Mol Med. 2005;11:43\u20138.","journal-title":"Trends Mol Med."},{"key":"117_CR87","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3109\/09546634.2015.1088131","volume":"27","author":"MJ Geel van","year":"2016","unstructured":"van Geel MJ, van de Kerkhof PC, Oostveen AM, de Jong EM, Seyger MM. Fumaric acid esters in recalcitrant pediatric psoriasis: a prospective, daily clinical practice case series. J Dermatolog Treat. 2016;27:214\u201320.","journal-title":"J Dermatolog Treat."},{"key":"117_CR88","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1111\/bjd.12231","volume":"168","author":"DM Balak","year":"2013","unstructured":"Balak DM, Oostveen AM, Bousema MT, et al. Effectiveness and safety of fumaric acid esters in children with psoriasis: a retrospective analysis of 14 patients from The Netherlands. Br J Dermatol. 2013;168:1343\u20137.","journal-title":"Br J Dermatol"},{"key":"117_CR89","first-page":"50","volume":"14","author":"K Reich","year":"2016","unstructured":"Reich K, Hartl C, Gambichler T, Zschocke I. Retrospective data collection of psoriasis treatment with fumaric acid esters in children and adolescents in Germany (KIDS FUTURE study). J Dtsch Dermatol Ges. 2016;14:50\u20137.","journal-title":"J Dtsch Dermatol Ges."},{"issue":"3","key":"117_CR90","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000363103","volume":"229","author":"K Steinz","year":"2014","unstructured":"Steinz K, Gerdes S, Domm S, Mrowietz U. Systemic treatment with fumaric acid esters in six paediatric patients with psoriasis in a psoriasis centre. Dermatology. 2014;229(3):199\u2013204.","journal-title":"Dermatology"},{"key":"117_CR91","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00403-007-0744-y","volume":"299","author":"A Nast","year":"2007","unstructured":"Nast A, Kopp I, Augustin M, et al. German evidence-based guidelines for the treatment of psoriasis vulgaris (short version). Arch Dermatol Res. 2007;299:111\u201338.","journal-title":"Arch Dermatol Res"},{"key":"117_CR92","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1586\/1744666X.2014.873701","volume":"10","author":"M Lynch","year":"2014","unstructured":"Lynch M, Kirby B, Warren RB. Treating moderate to severe psoriasis\u2014best use of biologics. Expert Rev Clin Immunol. 2014;10:269\u201379.","journal-title":"Expert Rev Clin Immunol."},{"key":"117_CR93","first-page":"CD010017","volume":"11","author":"G Sanclemente","year":"2015","unstructured":"Sanclemente G, Murphy R, Contreras J, Garc\u00eda H, Bonfill Cosp X. Anti-TNF agents for paediatric psoriasis. Cochrane Database Syst Rev. 2015;11:CD010017.","journal-title":"Cochrane Database Syst Rev."},{"key":"117_CR94","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa066886","volume":"358","author":"AS Paller","year":"2008","unstructured":"Paller AS, Siegfried EC, Langley RG, et al. Etanercept treatment for children and adolescents with plaque psoriasis. N Engl J Med. 2008;358:241\u201351.","journal-title":"N Engl J Med"},{"key":"117_CR95","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jaad.2010.04.004","volume":"63","author":"AS Paller","year":"2010","unstructured":"Paller AS, Siegfried EC, Eichenfield LF, et al. Long-term etanercept in pediatric patients with plaque psoriasis. J Am Acad Dermatol. 2010;63:762\u20138.","journal-title":"J Am Acad Dermatol"},{"key":"117_CR96","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1002\/art.24777","volume":"60","author":"EH Giannini","year":"2009","unstructured":"Giannini EH, Ilowite NT, Lovell DJ, et al. Long-term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritis. Arthritis Rheum. 2009;60:2794\u2013804.","journal-title":"Arthritis Rheum"},{"key":"117_CR97","unstructured":"European Medicines Agency. Committee for medicinal products for human use (CHMP) Summary of opinion (post authorisation) for Enbrel (etanercept). July 21, 2011. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Summary_of_opinion\/human\/000262\/WC50010924.pdf ."},{"key":"117_CR98","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jaad.2015.09.056","volume":"74","author":"AS Paller","year":"2016","unstructured":"Paller AS, Siegfried EC, Langley RG, et al. Long-term safety and efficacy of etanercept in children and adolescents with plaque psoriasis. J Am Acad Dermatol. 2016;74:280\u20137.","journal-title":"J Am Acad Dermatol"},{"key":"117_CR99","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s00105-012-2337-8","volume":"63","author":"FC Beikert","year":"2012","unstructured":"Beikert FC, Augustin M, Radtke MA. Etanercept in juvenile psoriasis. Hautarzt. 2012;63:406\u201310.","journal-title":"Hautarzt."},{"key":"117_CR100","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1186\/1756-0500-7-929","volume":"7","author":"E Campione","year":"2014","unstructured":"Campione E, Diluvio L, Terrinoni A, et al. Severe erytrodermic psoriasis in child twins: from clinical-pathological diagnosis to treatment of choice through genetic analyses: two case reports. BMC Res Notes. 2014;7:929.","journal-title":"BMC Res Notes."},{"key":"117_CR101","doi-asserted-by":"crossref","first-page":"S144","DOI":"10.1590\/S0365-05962011000700038","volume":"86","author":"NA Fraga","year":"2011","unstructured":"Fraga NA, Paim Mde F, Follador I, et al. Refractory erythrodermic psoriasis in a child with an excellent outcome by using etanercept. An Bras Dermatol. 2011;86:S144\u20137.","journal-title":"An Bras Dermatol."},{"key":"117_CR102","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.0736-8046.2004.21121.x","volume":"21","author":"MA Menter","year":"2004","unstructured":"Menter MA, Cush JM. Successful treatment of pediatric psoriasis with infliximab. Pediatr Dermatol. 2004;21:87\u20138.","journal-title":"Pediatr Dermatol"},{"key":"117_CR103","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5070\/D33XF9F397","volume":"11","author":"NN Farnsworth","year":"2005","unstructured":"Farnsworth NN, George SJ, Hsu S. Successful use of infliximab following a failed course of etanercept in a pediatric patient. Dermatol Online J. 2005;11:11.","journal-title":"Dermatol Online J"},{"key":"117_CR104","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2133.2007.07928.x","volume":"157","author":"S Rott","year":"2007","unstructured":"Rott S, Kuster RM, Mrowietz U. Successful treatment of severe psoriatic arthritis with infliximab in an 11-year-old child suffering from linear psoriasis along lines of Blaschko. Br J Dermatol. 2007;157:191\u20132.","journal-title":"Br J Dermatol"},{"key":"117_CR105","doi-asserted-by":"crossref","unstructured":"Tsang V, Dvorakova V, Enright F, Gleeson C. Successful use of infliximab as first line treatment for severe childhood generalized pustular psoriasis. J Eur Acad Dermatol Venereol. 2015. (doi:10).","DOI":"10.1111\/jdv.13388"},{"issue":"1","key":"117_CR106","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/pde.12457","volume":"32","author":"A Skrabl-Baumgartner","year":"2015","unstructured":"Skrabl-Baumgartner A, Weger W, Salmhofer W, et al. Childhood generalized pustular psoriasis: longtime remission with combined infliximab and methotrexate treatment. Pediatr Dermatol. 2015;32(1):13\u20134.","journal-title":"Pediatr Dermatol"},{"key":"117_CR107","first-page":"1","volume":"18","author":"M Luu","year":"2013","unstructured":"Luu M, Cordoro KM. The evolving role of biologics in the treatment of pediatric psoriasis. Skin Therapy Lett. 2013;18:1\u20134.","journal-title":"Skin Therapy Lett."},{"key":"117_CR108","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1053\/j.gastro.2012.04.046","volume":"143","author":"JS Hyams","year":"2012","unstructured":"Hyams JS, Griffiths A, Markowitz J, et al. Safety and efficacy of adalimumab for moderate to severe Crohn\u2019s disease in children. Gastroenterology. 2012;143:365\u201374.","journal-title":"Gastroenterology"},{"key":"117_CR109","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/bjo.2006.103721","volume":"91","author":"S Biester","year":"2007","unstructured":"Biester S, Deuter C, Michels H, et al. Adalimumab in the therapy of uveitis in childhood. Br J Ophthal. 2007;91:319\u201324.","journal-title":"Br J Ophthal."},{"key":"117_CR110","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1080\/09546630500430604","volume":"16","author":"JP Callen","year":"2005","unstructured":"Callen JP, Jackson JH. Adalimumab effectively controlled recalcitrant generalized pustular psoriasis in an adolescent. J Dermatol Treat. 2005;16:350\u20132.","journal-title":"J Dermatol Treat."},{"key":"117_CR111","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1525-1470.2010.01219.x","volume":"28","author":"AC Alvarez","year":"2011","unstructured":"Alvarez AC, Rodriguez-Nevado I, De Argila D, et al. Recalcitrant pustular psoriasis successfully treated with adalimumab. Pediatr Dermatol. 2011;28:195\u20137.","journal-title":"Pediatr Dermatol"},{"key":"117_CR112","doi-asserted-by":"crossref","first-page":"588","DOI":"10.2340\/00015555-1540","volume":"93","author":"V Dini","year":"2013","unstructured":"Dini V, Barbanera S, Romanelli M. Efficacy of adalimumab for the treatment of refractory paediatric acrodermatitis continua of hallopeau. Acta Derm Venereol. 2013;93:588\u20139.","journal-title":"Acta Derm Venereol"},{"key":"117_CR113","unstructured":"http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR__Product_Information\/human\/000481\/WC500050870.pdf . Accessed 2 Mar 2016"},{"key":"117_CR114","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1684\/ejd.2010.1177","volume":"21","author":"C Fotiadou","year":"2011","unstructured":"Fotiadou C, Lazaridou E, Giannopoulou C, Ioannides D. Ustekinumab for the treatment of an adolescent patient with recalcitrant plaque psoriasis. Eur J Dermatol. 2011;21:117\u20138.","journal-title":"Eur J Dermatol."},{"key":"117_CR115","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/pde.12545","volume":"32","author":"M AbuHilal","year":"2015","unstructured":"AbuHilal M, Ho N. Successful treatment of severe psoriasis in an adolescent with ustekinumab. Pediatr Dermatol. 2015;32:377\u201380.","journal-title":"Pediatr Dermatol"},{"key":"117_CR116","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/ajd.12050","volume":"54","author":"S Dixit","year":"2013","unstructured":"Dixit S, Shumack S, Fischer G. Ustekinumab in the treatment of severe paediatric psoriasis. Aust J Dermatol. 2013;54:147.","journal-title":"Aust J Dermatol."},{"key":"117_CR117","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jaad.2015.07.002","volume":"73","author":"I Landells","year":"2015","unstructured":"Landells I, Colleen Marano, Hsu MC, et al. Ustekinumab in adolescent patients age 12 to 17\u00a0years with moderate-to-severe plaque psoriasis: results of the randomized phase 3 CADMUS study. J Am Acad Dermatol. 2015;73:594\u2013603.","journal-title":"J Am Acad Dermatol"},{"key":"117_CR118","unstructured":"http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR__Summary_for_the_public\/human\/003729\/WC500183132.pdf . Accessed 4 Apr 2016"},{"key":"117_CR119","unstructured":"http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Summary_of_opinion_-_Initial_authorisation\/human\/003746\/WC500177621.pdf . Accessed 4 Apr 2016"},{"key":"117_CR120","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1586\/17512433.2016.1129894","volume":"9","author":"T Jaleel","year":"2016","unstructured":"Jaleel T, Elmets C, Weinkle A, et al. Secukinumab (AIN-457) for the treatment of Psoriasis. Expert Rev Clin Pharmacol. 2016;9:187\u2013202.","journal-title":"Expert Rev Clin Pharmacol."},{"key":"117_CR121","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jaad.2015.09.001","volume":"74","author":"P Rich","year":"2016","unstructured":"Rich P, Gooderham M, Bachelez H, et al. Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with difficult-to-treat nail and scalp psoriasis: results of 2 phase III randomized, controlled trials (ESTEEM 1 and ESTEEM 2). J Am Acad Dermatol. 2016;74:134\u201342.","journal-title":"J Am Acad Dermatol"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-016-0117-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T17:34:09Z","timestamp":1692293649000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13555-016-0117-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,16]]},"references-count":121,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["117"],"URL":"https:\/\/doi.org\/10.1007\/s13555-016-0117-6","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,16]]}}}